Seqens Seqens

X
menu

    Market Place

    Market Place

    Post Enquiry

    Post Enquiry
    menu

    Find the latest Drugs in Development and Pipeline Prospector News of Zenara Pharma.

    Client Virtual Booth

    ZENARA PHARMA

    EVENTS

    • Webinars & Exhibitions

    PRESENTATION(s)

    VIDEO(s)

    DIGITAL CONTENT

    DEVELOPMENTS

    DOSSIERs // Finished Dosage Formulations

    INSPECTIONS & REGISTRATIONS

    PharmaCompass
    Contact SupplierContact Supplier
    Google MapGoogle Map
    Full View ScreenFull View Screen
    Biophore
    Zenara Pharma
    india-flag Flag
    Country
    Country
    India
    Address
    Address
    Plot No.83/B, 84 & 87 to 96, Phase - III, IDA Cherlapally, Hyderabad - 500 051
    Telephone
    Telephone
    +91 40-27260848
    Client Email
    Email
    info@biophore.com
    Client Website
    Website
    https://www.zenarapharma.com/
    Linkedin
    Linkedin
    https://www.linkedin.com/company/zenara-pharma-pvt-ltd/
    Twitter
    Twitter
    https://twitter.com/home
    Contact Info
    Others

    Full View ScreenFull Screen View
    • Development Update
    Virtual Booth Upload your Marketing & Sales content on your company Virtual Booth, click HERE

    Biophore, Its Subsidiary Zenara Pharma, Receive First Approval for Cannabidiol in India

    Details:

    Cannabinoid oral solution has received approval for the treatment of several neurological disorders. It functions by stimulating two receptors, cannabinoid receptor type 1 and type 2, within the endocannabinoid system, maintaining body's homeostatis.


    Lead Product(s): Cannabidiol

    Therapeutic Area: Neurology Product Name: Undisclosed

    Highest Development Status: ApprovedProduct Type: Small molecule

    Partner/Sponsor/Collaborator: Not Applicable

    Deal Size: Not Applicable Upfront Cash: Not Applicable

    Deal Type: Not Applicable May 15, 2023

    Biophore CB

    Iran Expo

    Not Confirmed

    envelop Contact Supplier
    • Development Update
    Virtual Booth Upload your Marketing & Sales content on your company Virtual Booth, click HERE

    Zenara Pharma, a Biophore Subsidiary, Gets DCGI Nod for Favipiravir Tablets

    Details:

    Favipiravir tablets will be sold under the brand name ‘Favizen’, is being manufactured at Zenara’s US FDA approved facility in Hyderabad.


    Lead Product(s): Favipiravir

    Therapeutic Area: Infections and Infectious Diseases Product Name: Undisclosed

    Highest Development Status: ApprovedProduct Type: Small molecule

    Partner/Sponsor/Collaborator: Not Applicable

    Deal Size: Not Applicable Upfront Cash: Not Applicable

    Deal Type: Not Applicable August 05, 2020

    Biophore CB

    Iran Expo

    Not Confirmed

    envelop Contact Supplier
    Full Screen ViewFULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]
    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty

    Access Website

    Contact Supplier

    View Presentation

    Biophore

    Iran Expo

    Not Confirmed

    envelop Contact Supplier

    Post Enquiry
    POST ENQUIRY

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search